Our R&D Focus

Our R&D focus is on developing cell therapies for diabetes, cancer, neuronal diseases, and blood diseases.


Collaborations with biopharma and other research and development organizations form a core component of our strategy to accelerate the development of cell therapies. We pursue strategic partnerships for cell validation, pre-clinical testing, and therapy development. We view ourselves as the front-end provider of the cellular material and enabler of successful clinical programs.

Our Cell Therapy Programs


Bone Marrow Failure

Blood Diseases

Huntington's Disease

Parkinson's Disease

Other Programs

R&D Products